{"id":"af7652afc086","type":"article","url":"https://hartvaat.nl/2016/11/01/therapieresistente-hypertensie-na-sprint-evaluatie-en-management/","title":"Therapieresistente hypertensie na SPRINT: evaluatie en management","title_en":"Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era.","category":"hypertensie","category_label":"Hypertensie","professions":["cardioloog","huisarts","internist"],"tags":["bloeddrukbehandeling","farmaco-economie","niet-statine-therapie","resistente-hypertensie"],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.116.07316","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.116.07316","authors":["Raymond R Townsend","Murray Epstein"],"significance":7,"published":"2016-11-01","source_date":"2016-11-01","image":"","kennis":["https://hartvaat.nl/kennis/hypertensie/resistente-hypertensie/","https://hartvaat.nl/kennis/hypertensie/hypertensie-en-diabetes/"],"congress":"","summary_en":"This review discussed the evaluation and management of resistant hypertension in the context of SPRINT results, integrating intensive blood pressure targets with the diagnostic and therapeutic approach to treatment-resistant blood pressure.","created":"2026-07-03T10:26:23Z","updated":"2026-07-03T18:38:28Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Review over de evaluatie en behandeling van therapieresistente hypertensie in het post-SPRINT-tijdperk. Integreert de SPRINT-resultaten in het beleid bij patiënten die niet reageren op standaardbehandeling.","abstract_original":""}